VanEck Biotech ETF
Nasdaq-listed fund. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving VanEck Biotech ETF now
Current reporting with the operating signal separated from the noise.
iShares Global Healthcare ETF vs VanEck Biotech ETF: Which ETF Is Better for Profiting With Healthcare in 2026?
Investors are testing whether VanEck Biotech ETF’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Should You Invest in the VanEck Biotech ETF (BBH)?
The story matters when it changes VanEck Biotech ETF’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest BBH filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
No verified filing is shown until the official endpoint responds.
VanEck Biotech ETF, quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →